APO Research
Talk to an analyst

APO RESEARCH · REPORT

Stool Biomarkers Test

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Stool Biomarkers Test Market Outlook and Growth Opportunities 2026

4 July 2026190 pages

Choose your research edition.

Industry ResearchStool Biomarkers Test Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Stool Biomarkers Test Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Stool Biomarkers Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Stool Biomarkers Test Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Stool Biomarkers Test Market Analysis and Forecast 2026-2032173 pages · $4,950 USD

Market perspective

The global Stool Biomarkers Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Stool Biomarkers Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Stool Biomarkers Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Stool Biomarkers Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Stool Biomarkers Test market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Stool Biomarkers Test market include Genova Diagnostics, BioMrieux Inc, Actim, DiaSorin S.p.A., Beckman Coulter Inc., Alere Inc., Bio Rad Laboratories, Cenogenics Corporation and Siemens Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Stool Biomarkers Test market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Stool Biomarkers Test and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Stool Biomarkers Test revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Stool Biomarkers Test market.

Stool Biomarkers Test Segment by Company

Genova Diagnostics

BioMrieux Inc

Actim

DiaSorin S.p.A.

Beckman Coulter Inc.

Alere Inc.

Bio Rad Laboratories

Cenogenics Corporation

Siemens Healthcare

Quest Diagnostics Incorporated

Abbott Laboratories

Diagnose IBS

Meridian Bioscience Inc

Stool Biomarkers Test Segment by Type

Cologuard

M2 PK Stool Test

Others

Stool Biomarkers Test Segment by Application

Hospitals

Diagnostic Centres and Laboratories

Academic Institutions

Research Centres and Organizations

Stool Biomarkers Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Stool Biomarkers Test status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Stool Biomarkers Test key companies, revenue, market share, and recent developments.

3. To split the Stool Biomarkers Test breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Stool Biomarkers Test market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Stool Biomarkers Test significant trends, drivers, influence factors in global and regions.

6. To analyze Stool Biomarkers Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stool Biomarkers Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Stool Biomarkers Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stool Biomarkers Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Stool Biomarkers Test industry.

Chapter 3: Detailed analysis of Stool Biomarkers Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Stool Biomarkers Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Stool Biomarkers Test in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Stool Biomarkers Test Industry Trends Table 2. Stool Biomarkers Test Industry Drivers Table 3. Stool Biomarkers Test Industry Opportunities and Challenges Table 4. Stool Biomarkers Test Industry Restraints Table 5. Global Stool Biomarkers Test Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Stool Biomarkers Test Revenue Share by Company (2021-2026) Table 7. Global Stool Biomarkers Test Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Stool Biomarkers Test Key Company Manufacturing Base & Headquarters Table 9. Global Stool Biomarkers Test Company, Product Type & Application Table 10. Global Stool Biomarkers Test Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Stool Biomarkers Test by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cologuard Table 15. Significant Companies of M2 PK Stool Test Table 16. Significant Companies of Others Table 17. Global Stool Biomarkers Test Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Stool Biomarkers Test Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Stool Biomarkers Test Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Stool Biomarkers Test Sales Value Share by Type (2021-2026) Table 21. Global Stool Biomarkers Test Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Diagnostic Centres and Laboratories Table 24. Significant Companies of Academic Institutions Table 25. Significant Companies of Research Centres and Organizations Table 26. Global Stool Biomarkers Test Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Stool Biomarkers Test Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Stool Biomarkers Test Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Stool Biomarkers Test Sales Value Share by Application (2021-2026) Table 30. Global Stool Biomarkers Test Sales Value Share by Application (2027-2032) Table 31. Global Stool Biomarkers Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Stool Biomarkers Test Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Stool Biomarkers Test Sales Value Share by Region (2021-2026) Table 34. Global Stool Biomarkers Test Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Stool Biomarkers Test Sales Value Share by Region (2027-2032) Table 36. Global Stool Biomarkers Test Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Stool Biomarkers Test Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Stool Biomarkers Test Sales Value Market Share by Country (2021-2026) Table 39. Global Stool Biomarkers Test Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Stool Biomarkers Test Sales Value Market Share by Country (2027-2032) Table 41. Genova Diagnostics Company Information Table 42. Genova Diagnostics Business Overview Table 43. Genova Diagnostics Stool Biomarkers Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Genova Diagnostics Stool Biomarkers Test Product Portfolio Table 45. Genova Diagnostics Recent Development Table 46. BioMrieux Inc Company Information Table 47. BioMrieux Inc Business Overview Table 48. BioMrieux Inc Stool Biomarkers Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. BioMrieux Inc Stool Biomarkers Test Product Portfolio Table 50. BioMrieux Inc Recent Development Table 51. Actim Company Information Table 52. Actim Business Overview Table 53. Actim Stool Biomarkers Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Actim Stool Biomarkers Test Product Portfolio Table 55. Actim Recent Development Table 56. DiaSorin S.p.A. Company Information Table 57. DiaSorin S.p.A. Business Overview Table 58. DiaSorin S.p.A. Stool Biomarkers Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. DiaSorin S.p.A. Stool Biomarkers Test Product Portfolio Table 60. DiaSorin S.p.A. Recent Development Table 61. Beckman Coulter Inc. Company Information Table 62. Beckman Coulter Inc. Business Overview Table 63. Beckman Coulter Inc. Stool Biomarkers Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Beckman Coulter Inc. Stool Biomarkers Test Product Portfolio Table 65. Beckman Coulter Inc. Recent Development Table 66. Alere Inc. Company Information Table 67. Alere Inc. Business Overview Table 68. Alere Inc. Stool Biomarkers Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Alere Inc. Stool Biomarkers Test Product Portfolio Table 70. Alere Inc. Recent Development Table 71. Bio Rad Laboratories Company Information Table 72. Bio Rad Laboratories Business Overview Table 73. Bio Rad Laboratories Stool Biomarkers Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Bio Rad Laboratories Stool Biomarkers Test Product Portfolio Table 75. Bio Rad Laboratories Recent Development Table 76. Cenogenics Corporation Company Information Table 77. Cenogenics Corporation Business Overview Table 78. Cenogenics Corporation Stool Biomarkers Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Cenogenics Corporation Stool Biomarkers Test Product Portfolio Table 80. Cenogenics Corporation Recent Development Table 81. Siemens Healthcare Company Information Table 82. Siemens Healthcare Business Overview Table 83. Siemens Healthcare Stool Biomarkers Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Siemens Healthcare Stool Biomarkers Test Product Portfolio Table 85. Siemens Healthcare Recent Development Table 86. Quest Diagnostics Incorporated Company Information Table 87. Quest Diagnostics Incorporated Business Overview Table 88. Quest Diagnostics Incorporated Stool Biomarkers Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Quest Diagnostics Incorporated Stool Biomarkers Test Product Portfolio Table 90. Quest Diagnostics Incorporated Recent Development Table 91. Abbott Laboratories Company Information Table 92. Abbott Laboratories Business Overview Table 93. Abbott Laboratories Stool Biomarkers Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Abbott Laboratories Stool Biomarkers Test Product Portfolio Table 95. Abbott Laboratories Recent Development Table 96. Diagnose IBS Company Information Table 97. Diagnose IBS Business Overview Table 98. Diagnose IBS Stool Biomarkers Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Diagnose IBS Stool Biomarkers Test Product Portfolio Table 100. Diagnose IBS Recent Development Table 101. Meridian Bioscience Inc Company Information Table 102. Meridian Bioscience Inc Business Overview Table 103. Meridian Bioscience Inc Stool Biomarkers Test Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Meridian Bioscience Inc Stool Biomarkers Test Product Portfolio Table 105. Meridian Bioscience Inc Recent Development Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Stool Biomarkers Test Product Image Figure 2. Global Stool Biomarkers Test Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Stool Biomarkers Test Market Size (2021-2032) & (US$ Million) Figure 4. Global Stool Biomarkers Test Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cologuard Image Figure 8. M2 PK Stool Test Image Figure 9. Others Image Figure 10. Global Stool Biomarkers Test Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Stool Biomarkers Test Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Stool Biomarkers Test Sales Value Share by Type (2021-2032) Figure 13. Hospitals Image Figure 14. Diagnostic Centres and Laboratories Image Figure 15. Academic Institutions Image Figure 16. Research Centres and Organizations Image Figure 17. Global Stool Biomarkers Test Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Stool Biomarkers Test Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Stool Biomarkers Test Sales Value Share by Application (2021-2032) Figure 20. Global Stool Biomarkers Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Stool Biomarkers Test Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Stool Biomarkers Test Sales Value (2021-2032) & (US$ Million) Figure 23. North America Stool Biomarkers Test Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Stool Biomarkers Test Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Stool Biomarkers Test Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Stool Biomarkers Test Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Stool Biomarkers Test Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Stool Biomarkers Test Sales Value (2021-2032) & (US$ Million) Figure 29. South America Stool Biomarkers Test Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Stool Biomarkers Test Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Stool Biomarkers Test Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Stool Biomarkers Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Cologuard
  • M2 PK Stool Test
  • Others
Applications
  • Hospitals
  • Diagnostic Centres and Laboratories
  • Academic Institutions
  • Research Centres and Organizations
Companies covered
  • Genova Diagnostics
  • BioMrieux Inc
  • Actim
  • DiaSorin S.p.A.
  • Beckman Coulter Inc.
  • Alere Inc.
  • Bio Rad Laboratories
  • Cenogenics Corporation
  • Siemens Healthcare
  • Quest Diagnostics Incorporated
  • Abbott Laboratories
  • Diagnose IBS
  • Meridian Bioscience Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Stool Biomarkers Test Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Stool Biomarkers Test Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Stool Biomarkers Test Market Dynamics
  1. 2.1 Stool Biomarkers Test Industry Trends
  2. 2.2 Stool Biomarkers Test Industry Drivers
  3. 2.3 Stool Biomarkers Test Industry Opportunities and Challenges
  4. 2.4 Stool Biomarkers Test Industry Restraints
3 Stool Biomarkers Test Market by Company
  1. 3.1 Global Stool Biomarkers Test Company Revenue Ranking in 2025
  2. 3.2 Global Stool Biomarkers Test Revenue by Company (2021-2026)
  3. 3.3 Global Stool Biomarkers Test Company Ranking (2024-2026)
  4. 3.4 Global Stool Biomarkers Test Company Manufacturing Base and Headquarters
  5. 3.5 Global Stool Biomarkers Test Company Product Type and Application
  6. 3.6 Global Stool Biomarkers Test Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Stool Biomarkers Test Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Stool Biomarkers Test Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Stool Biomarkers Test Market by Type
  1. 4.1 Stool Biomarkers Test Type Introduction
  2. 4.1.1 Cologuard
  3. 4.1.2 M2 PK Stool Test
  4. 4.1.3 Others
  5. 4.2 Global Stool Biomarkers Test Sales Value by Type
  6. 4.2.1 Global Stool Biomarkers Test Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Stool Biomarkers Test Sales Value by Type (2021-2032)
  8. 4.2.3 Global Stool Biomarkers Test Sales Value Share by Type (2021-2032)
5 Stool Biomarkers Test Market by Application
  1. 5.1 Stool Biomarkers Test Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Diagnostic Centres and Laboratories
  4. 5.1.3 Academic Institutions
  5. 5.1.4 Research Centres and Organizations
  6. 5.2 Global Stool Biomarkers Test Sales Value by Application
  7. 5.2.1 Global Stool Biomarkers Test Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Stool Biomarkers Test Sales Value by Application (2021-2032)
  9. 5.2.3 Global Stool Biomarkers Test Sales Value Share by Application (2021-2032)
6 Stool Biomarkers Test Regional Value Analysis
  1. 6.1 Global Stool Biomarkers Test Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Stool Biomarkers Test Sales Value by Region (2021-2032)
  3. 6.2.1 Global Stool Biomarkers Test Sales Value by Region: 2021-2026
  4. 6.2.2 Global Stool Biomarkers Test Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Stool Biomarkers Test Sales Value (2021-2032)
  7. 6.3.2 North America Stool Biomarkers Test Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Stool Biomarkers Test Sales Value (2021-2032)
  10. 6.4.2 Europe Stool Biomarkers Test Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Stool Biomarkers Test Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Stool Biomarkers Test Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Stool Biomarkers Test Sales Value (2021-2032)
  16. 6.6.2 South America Stool Biomarkers Test Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Stool Biomarkers Test Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Stool Biomarkers Test Sales Value Share by Country, 2025 VS 2032
7 Stool Biomarkers Test Country-level Value Analysis
  1. 7.1 Global Stool Biomarkers Test Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Stool Biomarkers Test Sales Value by Country (2021-2032)
  3. 7.2.1 Global Stool Biomarkers Test Sales Value by Country (2021-2026)
  4. 7.2.2 Global Stool Biomarkers Test Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Stool Biomarkers Test Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Stool Biomarkers Test Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Stool Biomarkers Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Genova Diagnostics
  2. 8.1.1 Genova Diagnostics Company Information
  3. 8.1.2 Genova Diagnostics Business Overview
  4. 8.1.3 Genova Diagnostics Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Genova Diagnostics Stool Biomarkers Test Product Portfolio
  6. 8.1.5 Genova Diagnostics Recent Developments
  7. 8.2 BioMrieux Inc
  8. 8.2.1 BioMrieux Inc Company Information
  9. 8.2.2 BioMrieux Inc Business Overview
  10. 8.2.3 BioMrieux Inc Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BioMrieux Inc Stool Biomarkers Test Product Portfolio
  12. 8.2.5 BioMrieux Inc Recent Developments
  13. 8.3 Actim
  14. 8.3.1 Actim Company Information
  15. 8.3.2 Actim Business Overview
  16. 8.3.3 Actim Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Actim Stool Biomarkers Test Product Portfolio
  18. 8.3.5 Actim Recent Developments
  19. 8.4 DiaSorin S.p.A.
  20. 8.4.1 DiaSorin S.p.A. Company Information
  21. 8.4.2 DiaSorin S.p.A. Business Overview
  22. 8.4.3 DiaSorin S.p.A. Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DiaSorin S.p.A. Stool Biomarkers Test Product Portfolio
  24. 8.4.5 DiaSorin S.p.A. Recent Developments
  25. 8.5 Beckman Coulter Inc.
  26. 8.5.1 Beckman Coulter Inc. Company Information
  27. 8.5.2 Beckman Coulter Inc. Business Overview
  28. 8.5.3 Beckman Coulter Inc. Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Beckman Coulter Inc. Stool Biomarkers Test Product Portfolio
  30. 8.5.5 Beckman Coulter Inc. Recent Developments
  31. 8.6 Alere Inc.
  32. 8.6.1 Alere Inc. Company Information
  33. 8.6.2 Alere Inc. Business Overview
  34. 8.6.3 Alere Inc. Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Alere Inc. Stool Biomarkers Test Product Portfolio
  36. 8.6.5 Alere Inc. Recent Developments
  37. 8.7 Bio Rad Laboratories
  38. 8.7.1 Bio Rad Laboratories Company Information
  39. 8.7.2 Bio Rad Laboratories Business Overview
  40. 8.7.3 Bio Rad Laboratories Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bio Rad Laboratories Stool Biomarkers Test Product Portfolio
  42. 8.7.5 Bio Rad Laboratories Recent Developments
  43. 8.8 Cenogenics Corporation
  44. 8.8.1 Cenogenics Corporation Company Information
  45. 8.8.2 Cenogenics Corporation Business Overview
  46. 8.8.3 Cenogenics Corporation Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cenogenics Corporation Stool Biomarkers Test Product Portfolio
  48. 8.8.5 Cenogenics Corporation Recent Developments
  49. 8.9 Siemens Healthcare
  50. 8.9.1 Siemens Healthcare Company Information
  51. 8.9.2 Siemens Healthcare Business Overview
  52. 8.9.3 Siemens Healthcare Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Siemens Healthcare Stool Biomarkers Test Product Portfolio
  54. 8.9.5 Siemens Healthcare Recent Developments
  55. 8.10 Quest Diagnostics Incorporated
  56. 8.10.1 Quest Diagnostics Incorporated Company Information
  57. 8.10.2 Quest Diagnostics Incorporated Business Overview
  58. 8.10.3 Quest Diagnostics Incorporated Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Quest Diagnostics Incorporated Stool Biomarkers Test Product Portfolio
  60. 8.10.5 Quest Diagnostics Incorporated Recent Developments
  61. 8.11 Abbott Laboratories
  62. 8.11.1 Abbott Laboratories Company Information
  63. 8.11.2 Abbott Laboratories Business Overview
  64. 8.11.3 Abbott Laboratories Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Abbott Laboratories Stool Biomarkers Test Product Portfolio
  66. 8.11.5 Abbott Laboratories Recent Developments
  67. 8.12 Diagnose IBS
  68. 8.12.1 Diagnose IBS Company Information
  69. 8.12.2 Diagnose IBS Business Overview
  70. 8.12.3 Diagnose IBS Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Diagnose IBS Stool Biomarkers Test Product Portfolio
  72. 8.12.5 Diagnose IBS Recent Developments
  73. 8.13 Meridian Bioscience Inc
  74. 8.13.1 Meridian Bioscience Inc Company Information
  75. 8.13.2 Meridian Bioscience Inc Business Overview
  76. 8.13.3 Meridian Bioscience Inc Stool Biomarkers Test Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Meridian Bioscience Inc Stool Biomarkers Test Product Portfolio
  78. 8.13.5 Meridian Bioscience Inc Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst